Linfeng Zhao
No. 9, Seyuan Road
Nantong, 226019, China
Nantong, 226019, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A peptide immunomodulator activates MST1 to expand and stabilize murine and human regulatory T cells for immune tolerance.
Journal: Science translational medicine
Published: February 25, 2026
Multidimensional tumor-blood profiling uncovers systemic lymphocyte-monocyte imbalance in pituitary neuroendocrine tumors.
Journal: Signal transduction and targeted therapy
Published: May 27, 2025
LKB1 regulates ILC3 postnatal development and effector function through metabolic programming.
Journal: Frontiers in immunology
Published: March 04, 2025
Sirtuin 6 inhibits group 3 innate lymphoid cell function and gut immunity by suppressing IL-22 production.
Journal: Frontiers in immunology
Published: March 18, 2024
Single-cell transcriptomics reveal distinct immune-infiltrating phenotypes and macrophage-tumor interaction axes among different lineages of pituitary neuroendocrine tumors.
Journal: Genome medicine
Published: October 14, 2023
Metabolic regulator LKB1 controls adipose tissue ILC2 PD-1 expression and mitochondrial homeostasis to prevent insulin resistance.
Journal: Immunity
Published: August 18, 2023
LKB1 prevents ILC2 exhaustion to enhance antitumor immunity.
Journal: Cell reports
Published: November 01, 2022
Conjugated polymer-based luminescent probes for ratiometric detection of biomolecules.
Journal: Journal of materials chemistry. B
Published: June 22, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026